XPH

Fund Description
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible before expenses the total return performance of the S&P Pharmaceuticals Select Industry Index (ticker: SPSIPHTR).
Fund Profile
Fund Name SPDR S&P Pharmaceuticals ETF
Fund Exchange Ticker XPH
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A7220
Net Expense Ratio 0.35 %
Fund Inception Date 19 June 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Pharmaceuticals Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 21 June 2019
Asset Under Management 208.11 Million (USD)
1 Month Total Return -1.21 %
Year To Date Return 5.33 %
1 Year Total Return -13.76 %
3 Year Annualized Total Return -2.31 %
NAV 38.5367
Share Outstanding 5,400,270
Top 10 Holdings (21 June 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
ALLERGAN PLC AGN EQUI 0.0488162100
MYLAN NV MYL EQUI 0.0465684100
Elanco Animal Health Inc. ELAN EQUI 0.0456685200
NEKTAR THERAPEUTICS NKTR EQUI 0.0451551200
BRISTOL-MYERS SQUIBB CO BMY EQUI 0.0448747300
ELI LILLY & CO LLY EQUI 0.0447216300
PERRIGO CO PLC PRGO EQUI 0.0445807600
JAZZ PHARMACEUTICALS PLC JAZZ EQUI 0.0445536300
MERCK & CO. INC. MRK EQUI 0.0442034700
PFIZER INC PFE EQUI 0.0441769300